98%
921
2 minutes
20
Background: Digital health interventions offer opportunities to expand access to substance use disorder (SUD) treatment, collect objective real-time data, and deliver just-in-time interventions: however implementation has been limited. RAE (Realize, Analyze, Engage) Health is a digital tool which uses continuous physiologic data to detect high risk behavioral states (stress and craving) during SUD recovery.
Methods: This was an observational study to evaluate the digital stress and craving detection during outpatient SUD treatment. Participants were asked to use the RAE Health app, wear a commercial-grade wrist sensor over a 30-day period. They were asked to self-report stress and craving, at which time were offered brief in-app de-escalation tools. Supervised machine learning algorithms were applied retrospectively to wearable sensor data obtained to develop group-based digital biomarkers for stress and craving. Engagement was assessed by number of days of utilization, and number of hours in a given day of connection.
Results: Sixty percent of participants (N=30) completed the 30-day protocol. The model detected stress and craving correctly 76 % and 69 % of the time, respectively, but with false positive rates of 33 % and 28 % respectively. All models performed close to previously validated models from a research grade sensor. Participants used the app for a mean of 14.2 days (SD 10.1) and 11.7 h per day (SD 8.2). Anxiety disorders were associated with higher mean hours per day connected, and return to drug use events were associated with lower mean hours per day connected.
Conclusions: Future work should explore the effect of similar digital health systems on treatment outcomes and the optimal dose of digital interventions needed to make a clinically significant impact.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11260438 | PMC |
http://dx.doi.org/10.1016/j.drugalcdep.2024.111353 | DOI Listing |
BMJ Open
September 2025
Specialty of Addiction Medicine, The University of Sydney School of Medicine, Sydney, New South Wales, Australia.
Introduction: Current treatments for alcohol use disorders (AUD) have limited efficacy. A previous 28-day pilot trial of N-acetyl cysteine (NAC) vs placebo found NAC to be feasible and safe, with evidence of improvement on some measures of alcohol consumption. Thus, the primary aim of the NAC-AUD study is to examine the therapeutic and cost-effectiveness of NAC vs placebo in improving treatment outcomes for AUD.
View Article and Find Full Text PDFDrug Alcohol Depend
August 2025
Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Anesthesiology, School of Medicine, University of Virginia, Charlottesville, VA, USA.
Background: Craving is an aversive state and risk factor for progression to nonmedical substance use. The aims of this secondary analysis of Ecological Momentary Assessment (EMA) data were 1) to test whether craving was elevated on days of co-use of opioids and cannabis, and 2) to examine pain, pain catastrophizing, affect, and stress as risk factors for current and next-moment craving, among patients with chronic pain.
Methods: Adults with chronic pain (N = 46) who used both opioids and cannabis were recruited online and completed a 30-day EMA study, consisting of four momentary surveys per day that assessed opioids and cannabis craving, use, pain and pain catastrophizing, affect, and stress.
Issues Ment Health Nurs
September 2025
Mental Health Nursing Department, Faculty of Health Sciences, Kutahya Health Sciences University, Kutahya, Turkey.
Stimulant use disorder (methamphetamine) represents a significant challenge in correctional settings, where over 40% of incarcerated individuals may be affected. Despite limited access to evidence-based treatments, psychiatric nurses are uniquely positioned to deliver psychosocial interventions. This randomized controlled trial evaluated an 8-week nurse-led cognitive behavioural therapy intervention among 72 incarcerated men with stimulant use disorder (methamphetamine) in Turkey.
View Article and Find Full Text PDFSubst Use Misuse
September 2025
Center on Mindfulness and Integrative Health Intervention Development, University of Utah, Salt Lake City, USA.
: Polysubstance use is common in alcohol use disorder (AUD) and associated with poor treatment outcomes. Cannabis and cocaine often co-used with alcohol, have no approved medication treatments and respond poorly to common behavioral treatments. Thus, treatments that can reduce use of these substances alongside AUD are critically needed.
View Article and Find Full Text PDFBehav Sci (Basel)
July 2025
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29403, USA.
Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) often co-occur and present significant treatment challenges. Cognitive Processing Therapy (CPT) is a widely used, efficacious treatment for PTSD, but the application of CPT among individuals with co-occurring PTSD/AUD has been limited. To address this gap, we developed a novel, 12-session trauma-focused treatment that combines CPT with Relapse Prevention (RP) for AUD (CPT+RP).
View Article and Find Full Text PDF